1
Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression
Condition(s):Bipolar Depression; Treatment Effectiveness; Measure-based GuidanceLast Updated:June 26, 2018Unknown status
Oxcarbazepine as an Intervention: 67 Clinical Trials, Page 1 of 7
Hide Studies Not Open or Pending
2
Oxcarbazepine for the Treatment of Chronic Peripheral Neuropathic Pain
Condition(s):Polyneuropathy; Peripheral Nerve Injury; Postherpetic NeuralgiaLast Updated:May 5, 2014Completed
3
Protective Role of Oxcarbazepine in Multiple Sclerosis
Condition(s):Multiple SclerosisLast Updated:April 18, 2018Completed
4
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fasted Conditions
Condition(s):SeizuresLast Updated:January 23, 2018Completed
5
Effect of Oxcarbazepine on Serum Brain Derived Neurotrophic Factor (BDNF) in Bipolar Disorder
Condition(s):Bipolar DisorderLast Updated:May 7, 2019Completed
6
Tolerability and Pharmacokinetics of a Single 900 mg Oral Dose of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
Condition(s):EpilepsyLast Updated:January 8, 2015Completed
7
Crossover Bioequivalence Study of Oxcarbazepine 600 mg Suspension Under Fed Conditions
Condition(s):SeizuresLast Updated:January 23, 2018Completed
8
Oxcarbazepine Versus Placebo in Childhood Autism
Condition(s):AutismLast Updated:January 13, 2021Completed
9
EXTENT: EXtended Tolerability and Efficacy of a Novel Formulation of Oxcarbazepine in a Trial in Partial Epilepsy
Condition(s):Partial EpilepsyLast Updated:April 15, 2010Terminated
10
Oxtellar Extended Release (Oxcarbazepine Extended Release) Patients With Trigeminal Neuralgia
Condition(s):Trigeminal NeuralgiaLast Updated:November 1, 2019Withdrawn